| Schedule of segment reporting information, by segment |
| | | | | | | | | For the three months ended | | | September 30, | | | 2021 | | 2020 | Revenue | | | | | | | XpresSpaTM | | $ | 1,415 | | $ | 140 | XpresTestTM | | | 25,351 | | | — | TreatTM | | | — | | | — | Corporate and other | | | — | | | 61 | Total revenue | | $ | 26,767 | | $ | 201 | | | | | | | | | | | | | | | Operating income (loss) | | | | | | | XpresSpaTM | | $ | (1,595) | | $ | (5,699) | XpresTestTM | | | 12,015 | | | (1,791) | TreatTM | | | (2,305) | | | — | Corporate and other | | | (1,058) | | | (1,733) | Total operating income (loss) | | $ | 7,057 | | $ | (9,223) | | | | | | | | | | | | | | | | | For the nine months ended | | | September 30, | | | 2021 | | 2020 | Revenue | | | | | | | XpresSpaTM | | $ | 2,172 | | $ | 7,729 | XpresTestTM | | | 42,199 | | | — | TreatTM | | | — | | | — | Corporate and other | | | — | | | 333 | Total revenue | | $ | 44,371 | | $ | 8,062 | | | | | | | | | | | | | | | Operating income (loss) | | | | | | | XpresSpaTM | | $ | (4,828) | | $ | (16,103) | XpresTestTM | | | 14,597 | | | (1,791) | TreatTM | | | (4,115) | | | — | Corporate and other | | | (3,719) | | | (4,761) | Total operating income (loss) | | $ | 1,935 | | $ | (22,655) |
| | | | | | | | | | | | | | | | September 30, | | September 30, | | | 2021 | | 2020 | Assets | | | | | | | XpresSpaTM | | $ | 15,278 | | $ | 5,816 | XpresTestTM | | | 19,428 | | | — | TreatTM | | | 3,116 | | | — | Corporate and other | | | 91,455 | | | 75,713 | Total assets | | $ | 129,277 | | $ | 81,529 |
|